Psychopharmacology Maastricht

The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.

Learn More
hero-decor

Maastricht Psychedelic Symposium

On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).

Click below to watch the entire symposium

Watch the Live Stream
img-2-intro
featured study

Read about our new paper on the neurological origins of a visual psychedelic hallucination

Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.

Read The Paper

Participate in our studies!

We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.

View All Studies
img-2-intro

Prof. Arjan Blokland

Cognition, Learning & Memory, Acetylcholine

I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.

Dr. Kim Kuypers

Microdosing, Cognition, Nutrition

My research focuses on the neurobiology of flexible cognition, empathy, and well-being.

Dr. Malin Vedøy Uthaug

Ayahuasca, 5-MeO-DMT, Consciousness

I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.

Dr. Natasha Mason

Psychedelics, Neuroadaptations, Plasticity

My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.

Aedan O’Shea, MSc

Exosomes, miRNA, RDoC

I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...

Iva Totomanova, MSc

ADHD, LSD, Microdosing

My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.

Johannes Reckweg, MSc

5-MeO-DMT, Neuropsychopharmacology, Therapy

I am Johannes, a PhD candidate from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.

Dr. Rudy Schreiber

CNS Drug Discovery, Research Domain Criteria

I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies

Dr. Conny Quaedflieg

Stress Resilience, Intentional Forgetting, EEG

Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.

We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.

Copyright 2024 © Psychopharmacology Department at Maastricht University, All Rights Reserved